Home > Press > Advance Nanotech Retains Investor Relations International for Strategic IR Campaign
Advance Nanotech, Inc. (OTCBB:AVNA), a leading provider of financing and support services to drive the commercialization of nanotechnology-related products for homeland security and display technologies, today announced that it has retained Investor Relations International (IRI) to lead an expanded shareholder communication program.
Advance Nanotech Retains Investor Relations International for Strategic IR Campaign
NEW YORK, NY | Posted on April 18th, 2007
As investor relations counsel for Advance Nanotech, Los Angeles-based IRI will raise investor awareness of the company's performance through print and electronic media as well as direct communication with money managers and current or prospective shareholders. The IRI program, focused on Advance Nanotech's outlook and the execution of its growth strategy, seeks to expand the company's capital resources by broadening the company's shareholder base as well as cementing the long-term loyalty of current shareholders.
"We are pleased to have Investor Relations International working with us to raise our profile and make the broad investment community fully understand our exciting growth prospects," said Tony Goncalves, CEO of Advance Nanotech. "Our company is at a pivotal point in its history, with its first product now generating revenue in the homeland security market and a potentially lucrative portfolio of other products nearing commercialization. IRI's well-known expertise in explaining corporate strategies effectively and in generating both liquidity and shareholder value will serve us well."
To be added to Advance Nanotech's investor e-mail lists, please contact Haris Tajyar at .
About Advance Nanotech, Inc.
Advance Nanotech, Inc. identifies patented, patent-pending and proprietary technologies at leading universities and funds the additional development of such technologies in exchange for the exclusive rights to commercialize any resulting products. The company has interests in nanotechnologies that are grouped into two operating subsidiaries: Advance Display Technologies plc, which is listed on the PLUS-Quoted market in London (ADTP) and Advance Homeland Security plc.
By partnering with universities and leveraging the infrastructure and multi-disciplinary human resources of its university partners, Advance Nanotech reduces its cost base and mitigates risk. After prototypes are proven within the lab and the company develops a product roadmap and business plan, it forms majority-owned subsidiaries around the specific technology. It seeks to return value to shareholders through the sale or licensing of the technology, by securing additional financing for the subsidiary from either the venture capital community or the capital markets, or by successfully executing its business plan and consolidating its income as the majority shareholder. For more information on Advance Nanotech, please visit http://www.advancenanotech.com .
About Investor Relations International
Investor Relations International (IRI), based in Los Angeles, is a leading investor relations firm serving a worldwide client base. The principals of IRI have developed award-winning investor relations programs for a number of NYSE and Nasdaq-listed companies such as Insmed Inc., Internet Capital Group, LJ International, Starwood Hotels & Resorts Worldwide, ValueVision International and others, and have assisted dozens of public companies ranging from emerging small-cap companies to multinational corporations with market capitalizations in excess of $15 billion. IRI designs and implements customized investor relations programs to meet each client’s unique needs. It enjoys one of the highest client retention rates in the industry.
For more information on IRI, please visit the Company’s website at http://www.irintl.com .
Forward-looking statements: This news release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These statements are based upon our current expectations and speak only as of the date hereof. Our actual results may differ materially and adversely from those expressed in any forward-looking statements as a result of various factors and uncertainties, including the recent economic slowdown affecting technology companies, the future success of our scientific studies, our ability to successfully develop products, rapid technological change in our markets, changes in demand for our future products, legislative, regulatory and competitive developments and general economic conditions. Our Annual Report on Form 10-K and 10-K/A, recent and forthcoming Quarterly Reports on Form 10-Q and 10-Q/A, recent Current Reports and other SEC filings discuss some of the important risk factors that may affect our business, results of operations and financial condition. We undertake no obligation to revise or update publicly any forward-looking statements for any reason.
For more information, please click here
Advance Nanotech, Inc.
Tom Black, 212-583-0080
Copyright © Business Wire 2007
If you have a comment, please Contact
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Harris & Harris Group Continues Its Blog Series to Highlight Most Impactful Portfolio Companies With Champions Oncology, Inc. April 17th, 2014
Nanometrics to Announce First Quarter Financial Results on April 29, 2014 April 9th, 2014
Harris & Harris Group Notes Mersana's Collaboration Agreement With Subsidiary of Takeda Pharmaceutical Co. April 8th, 2014
Harris & Harris Group Continues Its Blog Series to Highlight Most Impactful Portfolio Companies With Metabolon, Inc. April 7th, 2014
MRI, on a molecular scale: Researchers develop system that could one day peer into the atomic structure of individual molecules April 20th, 2014
Iranian Researchers Present New Model to Strengthen Superconductivity at Higher Temperatures April 19th, 2014
Iranian Researchers Produce New Anti-Cancer Drug from Turmeric April 19th, 2014
Innovative strategy to facilitate organ repair April 18th, 2014
Nanobiotix Appoints Thierry Otin as Head of Manufacturing and Supply April 15th, 2014
Industry Veteran Fergus Clarke Joins Picodeon as CEO: Appointment comes as Picodeon prepares for growth April 8th, 2014
Peter B. Littlewood appointed Director of Argonne National Laboratory March 26th, 2014
Global 450 consortium announces new general manager of internal operations: TSMC’s Cheng-Chung Chien Receives Unanimous Support, Brings History of Innovation and Efficiency to Global Consortium of Companies Driving Industry Transition to 450mm Wafer Technology March 26th, 2014